Aitia is a leading AI-enabled biotech company based in Somerville, MA, dedicated to discovering breakthrough drugs and unraveling hidden biological mechanisms of disease. By leveraging causal AI, human multi-omics data, and their innovative Gemini Digital Twins, Aitia aims to accelerate the development of life-saving therapeutics, making a significant impact on patients' lives.
With their disruptive AI approaches, Aitia is poised to revolutionize drug discovery, particularly in neurodegenerative diseases, prioritizing programs that address the devastating effects on patients and their families. Backed by a world-class team of AI pioneers, R&D veterans, and biotech experts, Aitia collaborates with industry-leading companies across various therapeutic areas to pave the way for groundbreaking therapies and shape the future of biotech.
Generated from the website